Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

@Fynnderella1 The 'Conflict of Interest' statement says it all.😵‍💫 https://t.co/73mbAY8l6A

2.“For vaccines against SARS-CoV-2, a mucosal infection with a short incubation period, protection from severe disease is the only reasonable and attainable goal” Offit’s only reference of vax’s efficiency for severe outcome is this study https://t.co/J5S…

@BobP05608794 Right — That’s why him saying it caught my attention. I’d note that he was not talking about mandates at VRBPAC. https://t.co/CDHzVgycUa at 7:37:22 (also 7:21:40) I think the paper he mentions to show that 2-dose primary series was fine pr…

@TonyHui99 @katieorourke78 @Top_Muppetries @carlsmythe @CoralBlob @LiamKav @Monstercoyliar @crabb_vicki @mcfunny @BottomleyFiona @Kibbysma @_mamadeb @ncdave4life @Kingey16 @AndrewLazarus4 @TonyBaduy @FrankDElia7 @quigley_jesse @foofdawg @Mchael21592783M @…